Doximity (DOCS) fell approximately 25% to an all-time low following disappointing Q4 fiscal 2026 results, leading to a downgrade by KeyBanc Capital Markets. The company's guidance did not meet Wall Street expectations, marking the lowest stock price since its IPO in 2021.